MedTrace Logo

Bridging Intestinal Failure With Teduglutide - a Case Report

NCT04916665 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2021-06-07

No results posted yet for this study

Summary

In this case report the investigators present a novel strategy for using teduglutide as a bridging therapy to intestinal reconstruction.

Conditions

  • Short Bowel Syndrome

Interventions

DRUG

Teduglutide

bridging intestinal failure with teduglutide until reconstruction

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04916665 on ClinicalTrials.gov